Download Free Sample Report

The global MRD Testing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The USA market for Global MRD Testing market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The China market for Global MRD Testing market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

The Europe market for Global MRD Testing market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.

Minimal residual disease (MRD) testing is the future of diagnostics and monitoring for cancer, according to some experts. Not only can MRD determine the depth of response to a treatment, but it can also be used to determine treatment strategies.
This report aims to provide a comprehensive presentation of the global market for MRD Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRD Testing. This report contains market size and forecasts of MRD Testing in global, including the following market information:

• Global MRD Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global top five companies in 2023 (%)

The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Flow Cytometry Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of MRD Testing include ICON, ArcherDX, Arup Laboratories, ASURAGEN INC, Cergentis B.V., Bio-Rad Laboratories, Mission Bio, Guardant Health and Invivoscribe, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the MRD Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global MRD Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global MRD Testing Market Segment Percentages, by Type, 2023 (%)

• Flow Cytometry
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing (NGS)
• Other Technologies

Global MRD Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global MRD Testing Market Segment Percentages, by Application, 2023 (%)

• Specialty Clinics and Hospitals
• Diagnostic Laboratories
• Research Institutions
• Other End Users

Global MRD Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global MRD Testing Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies MRD Testing revenues in global market, 2019-2024 (estimated), ($ millions)
• Key companies MRD Testing revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• ICON
• ArcherDX
• Arup Laboratories
• ASURAGEN INC
• Cergentis B.V.
• Bio-Rad Laboratories
• Mission Bio
• Guardant Health
• Invivoscribe
• Laboratory Corporation of America Holdings
• Inivata Ltd
• Natera, Inc
• NeoGenomics Laboratories, Inc
• Opko Health
• Quest Diagnostics Incorporated
• Sysmex Corporation
• Adaptive Biotechnologies Corporation

Outline of Major Chapters:
Chapter 1: Introduces the definition of MRD Testing, market overview.
Chapter 2: Global MRD Testing market size in revenue.
Chapter 3: Detailed analysis of MRD Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of MRD Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.